A phase 2 RCT evaluated progression of prostate-specific antigen and urinary symptoms in men with low-risk prostate cancer who were administered phytochemical-rich food and Lactobacillus probiotic ...

Following the 2025 ESMO Congress, Dr. Joshua Saba sat down with Dr. Chandler Park to discuss recent advances in prostate cancer care.

The two drugs—apalutamide and finasteride—were tested in lab experiments using mice and human cells affected by AML. The ...

BALTIMORE, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), and the Prostate Cancer Foundation (PCF) today ...

Announced completion of dose exploration portion of ORIC-944 Phase 1b clinical trial and presented data that continues to demonstrate potential ...

The post COVID Shots Are Not Causing a 'Turbo Cancer' Epidemic appeared first on Reason.com.

Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute ...

A prostate cancer diagnosis and life during and after treatments can feel overwhelming. Alongside the shock of a diagnosis, ...

In older cancer patients, receiving federal housing assistance is associated with earlier-stage diagnosis of breast cancer, ...

Presented new subgroup analyses from phase 3 clinical trial of CAN-2409 in localized prostate cancer at the American Society for Radiation ...

Prostate-specific antigen screening resulted in 13% lower prostate cancer mortality over a median 23 years of follow-up.

But a new study suggests one more factor deserves serious attention—chronological age. Researchers from University Hospitals ...